LaNova Medicines Limited
Registry sponsor category
Industry
- Other names
- LaNova Medicines Limited
- Company name
- LaNova Medicines Limited
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (17)
- A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours
- A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
- A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
- A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors
- A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours
- A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours
- A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid Tumors
- A Study of LM-24C5 For Advanced Solid Tumors
- A Study of LM-350 in Subjects With Advanced Solid Tumours
- A Study of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid Tumors
- LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma
- Phase II Study of LM-24C5
- Study of LM-061 in Subjects in Advanced Tumors
- Study of LM-102 in Subjects in Advanced Tumors
- Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours
- Study of LM-299 in Subjects Advanced Malignant Tumors
- Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell Diseases